Elad Sharon, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    D.E. Shaw Research
    Date added:
    08/28/2024
    Date updated:
    08/28/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Mallinckrodt Pharmaceuticals
    Topic:
    Advisory Board
    Date added:
    08/28/2024
    Date updated:
    08/28/2024
Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology